Eli Lilly's obesity drug succeeds in two late-stage studies

(Reuters) -Eli Lilly said on Thursday its experimental obesity drug met the main goals in two late-stage studies, with the drug helping patients reduce 26.6% weight on average in one of the studies following intensive lifestyle changes. Read full story

Source : https://www.thestar.com.my/news/world/2023/07/27/eli-lilly039s-obesity-drug-succeeds-in-two-late-stage-studies